Ticker: ADTX

Company: Aditx Therapeutics, Inc.

Person: Corinne Pankovcin, officer

Transaction date: Nov. 25, 2025

Reporting date: Nov. 26, 2025

Average share price: 3.2

Sold 1.0 shares for 3.2